MOCS2

Chr 5AR

molybdenum cofactor synthesis 2

Also known as: MCBPE, MOCO1, MOCODB, MOCODB1, MPTS

Eukaryotic molybdoenzymes use a unique molybdenum cofactor (MoCo) consisting of a pterin, termed molybdopterin, and the catalytically active metal molybdenum. MoCo is synthesized from precursor Z by the heterodimeric enzyme molybdopterin synthase. The large and small subunits of molybdopterin synthase are both encoded from this gene by overlapping open reading frames. The proteins were initially thought to be encoded from a bicistronic transcript. They are now thought to be encoded from monocistronic transcripts. Alternatively spliced transcripts have been found for this locus that encode the large and small subunits. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.391 OMIM phenotype
Clinical SummaryMOCS2
🧬
Gene-Disease Validity (ClinGen)
sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
53 unique Pathogenic / Likely Pathogenic· 140 VUS of 407 total submissions
📖
GeneReview available — MOCS2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.39LOEUF
pLI 0.000
Z-score 0.79
OE 0.71 (0.391.39)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.08Z-score
OE missense 1.02 (0.871.21)
101 obs / 98.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.71 (0.391.39)
00.351.4
Missense OE?1.02 (0.871.21)
00.61.4
Synonymous OE?0.86
01.21.6
LoF obs/exp: 6 / 8.5Missense obs/exp: 101 / 98.8Syn Z: 0.71
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMOCS2-related molybdenum cofactor deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.76top 25%
GOF
0.6737th %ile
LOF
0.3164th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

407 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic19
VUS140
Likely Benign155
Benign30
Conflicting20
34
Pathogenic
19
Likely Pathogenic
140
VUS
155
Likely Benign
30
Benign
20
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
26
5
3
0
34
Likely Pathogenic
17
1
1
0
19
VUS
3
101
34
2
140
Likely Benign
0
14
75
66
155
Benign
0
2
28
0
30
Conflicting
20
Total4612314168398

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 16) ClinVar copy-number / structural variants overlap MOCS2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MOCS2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →